Keurig Dr Pepper Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Keurig Dr Pepper Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 25.30 $ to 33.50 $ · Last price: 31.40 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/17/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Beverages - Non-Alcoholic
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Keurig Dr Pepper Inc KDP | 43.0 | 24.3 | 16.7 | 51.0 | 19.0 | 8.2 | 21.9 |
| The Coca-Cola Company KO | 379.1 | 28.1 | 20.5 | 61.9 | 35.1 | 1.9 | 34.9 |
| PepsiCo Inc PEP | 181.0 | 21.6 | 12.3 | 54.2 | 17.0 | 2.3 | -1.5 |
| Coca-Cola European Partners PLC CCEP | 44.4 | 19.6 | 13.2 | 35.6 | 13.4 | 2.3 | 18.8 |
| Monster Beverage Corp MNST | 43.5 | 22.0 | 30.3 | 55.6 | 31.0 | 10.7 | 33.8 |
| Coca-Cola Consolidated Inc. COKE | 13.3 | 28.6 | 14.5 | 39.1 | 7.4 | 4.8 | 68.9 |
| Celsius Holdings Inc CELH | 7.5 | 74.3 | 37.7 | 48.8 | 19.8 | 85.5 | -49.7 |
| Primo Brands Corporation PRMB | 7.4 | 114.0 | 11.4 | 30.8 | 11.0 | 29.3 | -4.4 |
| Embotelladora Andina S.A AKO-B | 4.8 | 15.9 | 10.0 | 39.2 | 0.0 | -1.9 | 26.4 |
| Median of companies shown | 43.0 | 24.3 | 14.5 | 48.8 | 17.0 | 4.8 | 21.9 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 6,440 | 1,433 | 847 | 0.91 | 939 | 2,134 | 9,791 |
| 2017 | 6,690 | 1,388 | 1,076 | 1.18 | 1,038 | 2,451 | 10,022 |
| 2018 | 7,442 | 1,237 | 586 | 0.53 | 1,613 | 22,533 | 48,918 |
| 2019 | 11,120 | 2,378 | 1,254 | 0.88 | 2,474 | 23,257 | 49,518 |
| 2020 | 11,618 | 2,480 | 1,325 | 0.93 | 2,456 | 23,829 | 49,779 |
| 2021 | 12,683 | 2,894 | 2,146 | 1.50 | 2,874 | 24,972 | 50,598 |
| 2022 | 14,057 | 2,783 | 1,436 | 1.01 | 2,837 | 25,126 | 51,837 |
| 2023 | 14,814 | 3,194 | 2,181 | 1.55 | 1,329 | 25,676 | 52,130 |
| 2024 | 15,351 | 3,309 | 1,441 | 1.05 | 2,219 | 24,243 | 53,430 |
| 2025 | 16,603 | 3,653 | 2,079 | 1.53 | 1,991 | 25,516 | 55,459 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.11 | -121.30 | 4,070 | 5.20 | -3.50 | 849 | 674 |
| 2025: Q1 | 0.38 | 16.00 | 3,635 | 4.80 | 14.20 | 209 | 89 |
| 2025: Q2 | 0.40 | 6.10 | 4,163 | 6.10 | 13.10 | 431 | 323 |
| 2025: Q3 | 0.49 | 7.40 | 4,306 | 10.70 | 15.40 | 639 | 527 |
| 2025: Q4 | 0.26 | – | 4,499 | 10.50 | 7.80 | 712 | 566 |
| 2026: Q1 | 0.20 | -47.80 | 3,976 | 9.40 | 6.80 | 281 | 165 |
| 2026: Q2 | 0.04 | -90.00 | 7,309 | 75.60 | 1.90 | 895 | 714 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 6 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.29 | 2.25 – 2.34 | 26,310 | 11.9% | 19 |
| 12/31/2027 | 2.53 | 2.42 – 2.64 | 29,951 | 10.5% | 19 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 8.9% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $1.97B |
|---|---|
| Market cap | $43.03B |
| Free cash flow in year ten | $4.62B |
| Terminal value as a share of market value | 56.6% |
For comparison: over the past five years free cash flow shrank by 4.9% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 5.7%
- More than 10% revenue growth is expected for the coming year 13.7%
- Share count grows by less than 3% a year -1.6%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 17.2%
- Gross margin at 40% or higher and without meaningful erosion 54.2%
- Goodwill from acquisitions does not grow faster than revenue 36.5%
- Net debt below twice EBITDA 3.6 x EBITDA
- Operating cash flow covers the profits of the last three years -162 m
- Return on capital at 15% or higher, or up versus two years ago 7.7%
- Insiders hold at least 10% or are net buyers 5.0%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
7/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 11.1%
- Exp. sales growth 3Y > 5% 34.3%
- EBIT growth 10Y > 5% 11.0%
- Exp. EBIT growth 3Y > 5% 28.9%
- Net debt < 4x EBIT 4.1x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 13.7%
- Return on equity > 15% –
- ROCE > 15% 7.7%
- Expected return > 10% 33.4%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Gorli Eric | President, US Refreshment Bev. | Other | 1,306 | 31.58 | 41,243 |
| Sep 14, 2026 | Gorli Eric | President, US Refreshment Bev. | Other | 3,317 | 0.00 | – |
| Sep 14, 2026 | Shoemaker Anthony | Chief Legal Officer | Other | 23,833 | 31.58 | 752,646 |
| Sep 14, 2026 | Shoemaker Anthony | Chief Legal Officer | Other | 785 | 0.00 | – |
| Sep 14, 2026 | Shoemaker Anthony | Chief Legal Officer | Other | 59,781 | 0.00 | – |
| Sep 14, 2026 | Sandler Debra A. | Director | Other | 2,285 | 0.00 | – |
| Sep 9, 2026 | DeNooyer Mary Beth | Chief Human Resources Officer | Sell | 12,000 | 32.30 | 387,600 |
| Sep 8, 2026 | DeNooyer Mary Beth | Chief Human Resources Officer | Sell | 12,000 | 32.55 | 390,600 |
| Sep 3, 2026 | Stephens Angela A. | Senior VP & Controller | Sell | 9,500 | 32.70 | 310,650 |
| Aug 25, 2026 | Alt Aaron E | Director | Buy | 7,862 | 31.83 | 250,247 |
The company
About the Company
Keurig Dr Pepper Inc. besitzt, fertigt und vertreibt Getränke und Einzelportions-Brühsysteme in den USA und international.
- Employees
- 50,000
- Headquarters
- Frisco, TX
- Address
- 6425 Hall of Fame Lane, 75034 Frisco, United States
- Phone
- 800 527 7096
- Website
- keurigdrpepper.com
- IPO Date
- 09/21/1993
- ISIN
- US49271V1008
- Stock Split
- 2:1 on 06/01/1999
Management
| Name | Title | Birth Year |
|---|---|---|
| Timothy P. Cofer | CEO & Director | 1969 |
| Anthony P. DiSilvestro | Chief Financial Officer | 1959 |
| Anthony L. Shoemaker | Chief Legal Officer, General Counsel & Corporate Secretary | 1984 |
| Roger Johnson | Chief Transformation Officer | 1980 |
| Eric Gorli | President of U.S. Refreshment Beverages | 1975 |
| Robert P. Stiller | Founder | 1944 |
| Jane Gelfand | Vice President of Investor Relations & Strategic Initiatives | – |
| Andreas J. Panayiotou | Chief Marketing & Innovation Officer | – |
| Mary Beth DeNooyer | Chief Human Resources Officer | 1970 |
| Monique Oxender | Chief Corporate Affairs Officer | 1977 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 09/16/2026 Keurig Dr Pepper Inc. (KDP): Other Events; Financial Statements and Exhibits SEC ↗
- 09/01/2026 Keurig Dr Pepper Inc. (KDP): Other Events; Financial Statements and Exhibits SEC ↗
- 08/12/2026 Keurig Dr Pepper Inc. (KDP): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗
- 08/06/2026 Keurig Dr Pepper Inc. (KDP): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.